Company Filing History:
Years Active: 2004
Title: The Innovations of Gerard M Jensen
Introduction
Gerard M Jensen is a notable inventor based in Brea, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy of anti-tumor agents through advanced delivery systems.
Latest Patents
Gerard holds a patent for "Liposomal benzoquinazoline thymidylate synthase inhibitor formulations." This patent describes liposomal encapsulated formulations that improve pharmacokinetics and enhance the efficacy of benzoquinazoline thymidylate synthase inhibitors as anti-tumor agents. The formulations consist of liposomes that include at least one phosphatidylcholine, cholesterol, and the benzoquinazoline thymidylate synthase inhibitor.
Career Highlights
Gerard M Jensen is associated with Osi Pharmaceuticals, Inc., where he has been instrumental in advancing pharmaceutical innovations. His work has contributed to the development of more effective cancer treatments, showcasing his commitment to improving patient outcomes.
Collaborations
Throughout his career, Gerard has collaborated with esteemed colleagues, including Claudine S Ashvar and Su-Ming Chiang. These partnerships have fostered a collaborative environment that enhances the research and development of innovative pharmaceutical solutions.
Conclusion
Gerard M Jensen's contributions to the field of pharmaceuticals through his innovative patent and collaborations highlight his dedication to advancing cancer treatment. His work exemplifies the impact of innovation in improving healthcare solutions.